Hypertensive nephropathy. Moving from classic to emerging pathogenetic mechanisms
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Hypertension"
DOI: 10.1097/hjh.0000000000001170
Abstract: Hypertensive kidney disease classically entails nephroangiosclerosis and hyalinosis with glomerular damage. However, in recent years, several evidences showed that high blood pressure also injures tubular cells, inducing epithelial-to-mesenchymal transition and tubulointerstitial fibrosis. Recently investigated mechanisms… read more here.
Keywords: emerging pathogenetic; hypertensive nephropathy; moving classic; nephropathy moving ... See more keywords
MiR‐101a ameliorates AngII‐mediated hypertensive nephropathy by blockade of TGFβ/Smad3 and NF‐κB signalling in a mouse model of hypertension
Sign Up to like & getrecommendations! Published in 2019 at "Clinical and Experimental Pharmacology and Physiology"
DOI: 10.1111/1440-1681.13042
Abstract: Hypertensive nephropathy, clinically characterized by progressive renal fibrosis and inflammation, is a severe complication of hypertension. The objectives of this study were to investigate the roles of miR‐101a in relieving angiotensin II (Ang II)‐mediated hypertensive… read more here.
Keywords: hypertensive nephropathy; mir 101a; mouse model; tgf smad3 ... See more keywords
Disease Knowledge, Self-Efficacy, and Quality of Life in Patient With Hypertensive Nephropathy
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Nursing Research"
DOI: 10.1177/10547738211073396
Abstract: The purpose of this study is to investigate the relationships among disease knowledge, self-efficacy, and quality of life in patients with hypertensive nephropathy. A cross-sectional and correlational design is employed in this study, and a… read more here.
Keywords: disease knowledge; hypertensive nephropathy; quality life; self efficacy ... See more keywords
Development and Validation of Prediction Models for Hypertensive Nephropathy, the PANDORA Study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.794768
Abstract: Importance Hypertension is a leading cause of end-stage renal disease (ESRD), but currently, those at risk are poorly identified. Objective To develop and validate a prediction model for the development of hypertensive nephropathy (HN). Design,… read more here.
Keywords: prediction model; validation; development; prediction ... See more keywords
Effect of botanical drugs in improving symptoms of hypertensive nephropathy: Analysis of real-world data, retrospective cohort, network, and experimental assessment
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2023.1126972
Abstract: Background/aim: Hypertensive nephropathy (HN) is a common complication of hypertension. Traditional Chinese medicine has long been used in the clinical treatment of Hypertensive nephropathy. However, botanical drug prescriptions have not been summarized. The purpose of… read more here.
Keywords: botanical drugs; shen formula; gao shen; retrospective cohort ... See more keywords
Attenuating Effects of Dieckol on Hypertensive Nephropathy in Spontaneously Hypertensive Rats
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms22084230
Abstract: Hypertension induces renal fibrosis or tubular interstitial fibrosis, which eventually results in end-stage renal disease. Epithelial-to-mesenchymal transition (EMT) is one of the underlying mechanisms of renal fibrosis. Though previous studies showed that Ecklonia cava extracts… read more here.
Keywords: fibrosis; spontaneously hypertensive; hypertensive nephropathy; hypertensive rats ... See more keywords